Invalidity dossier

US 5268461

Alkylated oligosaccharides and acetyl derivatives of the same

Current assignee: DIC Corp

Added 9/23/2026, 4:55:59 PM

At a glanceNo PTAB challengesNo litigation on file

Active provider: DeepSeek · deepseek-flash

Patent summary

Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.

✓ Generated

US5268461A — Alkylated oligosaccharides and acetyl derivatives of the same

Bibliographic data (from the supplied source): Application US07/834,305; priority date 1990‑06‑27; filing date 1991‑06‑27; granted/publication date 1993‑12‑07. Original assignee Dainippon Ink and Chemicals Co Ltd; current assignee listed as DIC Corp. Inventors: Tadao Shoji, Nahoko Takahashi, Koichiro Adachi, Naoya Ikushima, Kaname Katsuraya, Toshiyuki Uryu, Takashi Yoshida. Legal status shown as "Expired – Fee Related," with anticipated expiration 2011‑06‑27. Classifications: C07H15/00, C07H15/02, C07H15/04, C07H3/00, C07H3/06.

Purpose: The patent concerns alkylated oligosaccharides and their acetyl derivatives, described as useful raw materials for low-toxicity surfactants or medicines. The compounds are said to act as surfactants because they combine hydrophilic sugar-chain moieties with hydrophobic alkyl groups, and to offer improved absorption relative to conventional polysaccharides owing to lower molecular weight.

Plain-language scope: The claimed subject matter, as described, covers compounds in which the hydrogen of the hydroxy group at the 1-position of the terminal sugar moiety of certain oligosaccharides is replaced by a linear or branched alkyl group. The oligosaccharide backbones are (a) oligosaccharides in which glucose moieties are β(1→4)-glycoside-linked, or (b) oligosaccharides in which galactose is β(1→4)-linked at the 4-position of the galactose moiety of lactose, with galactose moieties β(1→4)-linked in succession to the newly formed terminal galactose moieties. Alkyl groups have linear or branched chains of 1 to 22 carbon atoms, and the alkyl group is inserted at the anomer position. Acetyl derivatives, including compounds in which only the 2-positional hydroxy group adjacent to the alkyl-ether linkage is selectively deacetylated, are also described. The production method acetylates an oligosaccharide and reacts the acetylated product with an alcohol using a heteropolyacid (or Lewis acid) as reacting agent. Example compounds include n-dodecyl, n-heptyl, n-decyl and n-octadecyl galactopyranosyl-galactopyranosyl-glucopyranosides.

Not established by this excerpt: The excerpt is partial and omits the full claims, detailed examples, and any issued claim language. It does not establish claim scope as granted, validity, enforceability, litigation history, ownership transfers beyond the listed reassignment, or the content of the cited prior-art documents. No completeness of the compound list is warranted.

Source: https://patents.google.com/patent/[US5268461](/patent/US5268461)/en

Generated 10/1/2026, 9:44:01 PM

Cases on file (0)

Specific litigation cases in our database that name US patent 5268461. The free-form analysis below may also discuss cases beyond this list.

No cases on file mention this patent. Upload a CSV or add a case manually in Admin → Manage litigation cases.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Log in to generate
Not generated yet. Log in to request this analysis.

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Log in to generate
Not generated yet. Log in to request this analysis.

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Log in to generate
Not generated yet. Log in to request this analysis.

Prior art

Earlier patents, publications, and products that may anticipate or render the claims unpatentable.

Log in to generate
Not generated yet. Log in to request this analysis.

Obviousness

Combinations of prior art that suggest the claimed invention would have been obvious under 35 U.S.C. § 103.

Log in to generate
Not generated yet. Log in to request this analysis.

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Log in to generate
Not generated yet. Log in to request this analysis.

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Log in to generate
Not generated yet. Log in to request this analysis.